ADMA BIOLOGICS, INC. Quarterly Liabilities, Current in USD from Q2 2011 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Adma Biologics, Inc. quarterly Liabilities, Current history and growth rate from Q2 2011 to Q1 2025.
Adma Biologics, Inc. Liabilities, Current for the quarter ending March 31, 2025 was $53.5M, a 0.77% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$53.5M	+$410K	+0.77%	Mar 31, 2025	10-Q	2025-05-07
Q4 2024	$55.5M	+$5.74M	+11.5%	Dec 31, 2024	10-Q	2025-05-07
Q3 2024	$44.9M	+$3.05M	+7.29%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$44.2M	+$2.22M	+5.3%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$53.1M	+$16.4M	+44.5%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$49.8M	+$10.5M	+26.8%	Dec 31, 2023	10-K	2025-03-18
Q3 2023	$41.8M	-$2.6M	-5.85%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$42M	+$13.9M	+49.4%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$36.7M	+$5.16M	+16.4%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$39.3M	+$8.89M	+29.3%	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$44.4M	+$12.1M	+37.4%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$28.1M	+$9.89M	+54.4%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$31.6M	+$10.4M	+48.9%	Mar 31, 2022	10-Q	2022-05-11
Q4 2021	$30.4M	+$10.4M	+52.3%	Dec 31, 2021	10-K	2023-03-23
Q3 2021	$32.3M	+$15.9M	+96.3%	Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$18.2M	+$5.31M	+41.2%	Jun 30, 2021	10-Q	2021-08-11
Q1 2021	$21.2M	+$7.3M	+52.5%	Mar 31, 2021	10-Q	2021-05-12
Q4 2020	$19.9M	+$5.92M	+42.2%	Dec 31, 2020	10-K	2022-03-24
Q3 2020	$16.5M	+$1.32M	+8.74%	Sep 30, 2020	10-Q	2020-11-05
Q2 2020	$12.9M	+$2.75M	+27.2%	Jun 30, 2020	10-Q	2020-08-05
Q1 2020	$13.9M	+$5.57M	+66.8%	Mar 31, 2020	10-Q	2020-05-06
Q4 2019	$14M	+$4.4M	+45.7%	Dec 31, 2019	10-K	2021-03-25
Q3 2019	$15.2M	+$5.26M	+53.1%	Sep 30, 2019	10-Q	2019-11-06
Q2 2019	$10.1M	+$3.21M	+46.4%	Jun 30, 2019	10-Q	2019-08-08
Q1 2019	$8.34M	-$1.1M	-11.7%	Mar 31, 2019	10-Q	2019-05-08
Q4 2018	$9.63M	+$185K	+1.96%	Dec 31, 2018	10-K	2020-03-13
Q3 2018	$9.89M	-$3.45M	-25.8%	Sep 30, 2018	10-Q	2018-11-09
Q2 2018	$6.92M	-$8.73M	-55.8%	Jun 30, 2018	10-Q	2018-08-10
Q1 2018	$9.44M	-$3.52M	-27.1%	Mar 31, 2018	10-Q	2018-05-14
Q4 2017	$9.44M	-$1.78M	-15.9%	Dec 31, 2017	10-K	2019-03-13
Q3 2017	$13.3M	+$4.13M	+44.9%	Sep 30, 2017	10-Q	2017-11-03
Q2 2017	$15.6M	+$10.6M	+208%	Jun 30, 2017	10-Q	2017-08-11
Q1 2017	$13M	+$8.67M	+202%	Mar 31, 2017	10-Q	2017-05-12
Q4 2016	$11.2M	+$7.01M	+166%	Dec 31, 2016	10-K	2018-03-29
Q3 2016	$9.21M	+$4.91M	+114%	Sep 30, 2016	10-Q	2016-11-10
Q2 2016	$5.08M	+$1.88M	+58.8%	Jun 30, 2016	10-Q	2016-08-12
Q1 2016	$4.29M	+$504K	+13.3%	Mar 31, 2016	10-Q	2016-05-13
Q4 2015	$4.22M	+$18.6K	+0.44%	Dec 31, 2015	10-K	2017-02-24
Q3 2015	$4.3M	+$180K	+4.36%	Sep 30, 2015	10-Q	2015-11-10
Q2 2015	$3.2M	-$597K	-15.7%	Jun 30, 2015	10-Q	2015-08-11
Q1 2015	$3.79M	-$517K	-12%	Mar 31, 2015	10-Q	2015-05-12
Q4 2014	$4.2M	+$540K	+14.8%	Dec 31, 2014	10-K	2016-03-23
Q3 2014	$4.12M	+$1.6M	+63.6%	Sep 30, 2014	10-Q	2014-11-10
Q2 2014	$3.8M	+$1.77M	+87.2%	Jun 30, 2014	10-Q	2014-08-11
Q1 2014	$4.3M	+$2.2M	+105%	Mar 31, 2014	10-Q	2014-05-12
Q4 2013	$3.66M	+$1.84M	+101%	Dec 31, 2013	10-K	2015-03-09
Q3 2013	$2.52M	+$1.11M	+79.3%	Sep 30, 2013	10-Q	2013-11-12
Q2 2013	$2.03M	+$1.02M	+102%	Jun 30, 2013	10-Q	2013-08-12
Q1 2013	$2.1M	+$1.07M	+105%	Mar 31, 2013	10-Q	2013-05-14
Q4 2012	$1.82M	-$484K	-21%	Dec 31, 2012	10-K	2014-03-28

Previous1 2Next

Showing 1 to 50 of 56 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.